- Home
- WAL vs ASND Comparison
WAL vs ASND Comparison
Compare WAL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAL
- ASND
- Stock Information
- Founded
- WAL 1994
- ASND 2006
- Country
- WAL United States
- ASND Denmark
- Employees
- WAL N/A
- ASND N/A
- Industry
- WAL Major Banks
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- WAL Finance
- ASND Health Care
- Exchange
- WAL Nasdaq
- ASND Nasdaq
- Market Cap
- WAL 9.3B
- ASND 9.0B
- IPO Year
- WAL 2005
- ASND 2015
- Fundamental
- Price
- WAL $74.90
- ASND $151.08
- Analyst Decision
- WAL Strong Buy
- ASND Strong Buy
- Analyst Count
- WAL 15
- ASND 14
- Target Price
- WAL $98.07
- ASND $199.50
- AVG Volume (30 Days)
- WAL 1.2M
- ASND 547.2K
- Earning Date
- WAL 04-17-2025
- ASND 05-01-2025
- Dividend Yield
- WAL 1.97%
- ASND N/A
- EPS Growth
- WAL 8.41
- ASND N/A
- EPS
- WAL 7.09
- ASND N/A
- Revenue
- WAL $3,016,200,000.00
- ASND $376,478,932.00
- Revenue This Year
- WAL $13.49
- ASND $58.89
- Revenue Next Year
- WAL $10.02
- ASND $75.85
- P/E Ratio
- WAL $10.87
- ASND N/A
- Revenue Growth
- WAL 17.96
- ASND 36.34
- 52 Week Low
- WAL $53.75
- ASND $111.09
- 52 Week High
- WAL $98.10
- ASND $158.00
- Technical
- Relative Strength Index (RSI)
- WAL 34.74
- ASND 51.74
- Support Level
- WAL $71.58
- ASND $146.23
- Resistance Level
- WAL $87.68
- ASND $155.98
- Average True Range (ATR)
- WAL 3.35
- ASND 5.98
- MACD
- WAL -1.31
- ASND -1.48
- Stochastic Oscillator
- WAL 22.27
- ASND 43.61
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.